Patients with tumours lacking MMP-8 expression in cancer cells had a relative SCC mortality rate of 3.70 (95% CI 1.04–12.5) compared to patients with some MMP-8 positive immunostaining, when adjusted for age, sex, and stage of tumour (TNM) by the proportional hazards model. This evidence concerns the gene MMP8 and neoplasm.